113 related articles for article (PubMed ID: 22190048)
1. Translating volatile anesthetic-induced cardioprotection into systems biology.
Lotz C; Kehl F
Anesthesiology; 2012 Feb; 116(2):238-9. PubMed ID: 22190048
[No Abstract] [Full Text] [Related]
2. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?
Lucchinetti E; Bestmann L; Feng J; Freidank H; Clanachan AS; Finegan BA; Zaugg M
Anesthesiology; 2012 Feb; 116(2):296-310. PubMed ID: 22222469
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardioprotective effects of volatile anesthetics in children undergoing ventricular septal defect closure.
Singh P; Chauhan S; Jain G; Talwar S; Makhija N; Kiran U
World J Pediatr Congenit Heart Surg; 2013 Jan; 4(1):24-9. PubMed ID: 23799751
[TBL] [Abstract][Full Text] [Related]
4. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
Ansley DM; Raedschelders K; Chen DD; Choi PT
Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262
[TBL] [Abstract][Full Text] [Related]
5. Cardiac protection during on-pump coronary artery bypass grafting: ischemic versus isoflurane preconditioning.
Amr YM; Yassin IM
Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):205-11. PubMed ID: 20656748
[TBL] [Abstract][Full Text] [Related]
6. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
[TBL] [Abstract][Full Text] [Related]
7. Con: Ischemic preconditioning is not necessary because volatile agents accomplish it.
Piriou V; Chiari P
J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):803-5. PubMed ID: 15650998
[No Abstract] [Full Text] [Related]
8. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
[TBL] [Abstract][Full Text] [Related]
9. Is protection by inhalation agents volatile? Controversies in cardioprotection.
Zaugg M
Br J Anaesth; 2007 Nov; 99(5):603-6. PubMed ID: 17933798
[No Abstract] [Full Text] [Related]
10. The Discovery of Myocardial Preconditioning Using Volatile Anesthetics: A History and Contemporary Clinical Perspective.
Pagel PS; Crystal GJ
J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1112-1134. PubMed ID: 29398379
[No Abstract] [Full Text] [Related]
11. Volatile anesthetic-induced preconditioning.
Swyers T; Redford D; Larson DF
Perfusion; 2014 Jan; 29(1):10-5. PubMed ID: 24002781
[TBL] [Abstract][Full Text] [Related]
12. Commentary on: Volatile anesthetic-induced preconditioning.
Swyers T
Perfusion; 2014 Jan; 29(1):16. PubMed ID: 24002780
[No Abstract] [Full Text] [Related]
13. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins.
Raphael J; Abedat S; Rivo J; Meir K; Beeri R; Pugatsch T; Zuo Z; Gozal Y
J Pharmacol Exp Ther; 2006 Jul; 318(1):186-94. PubMed ID: 16551837
[TBL] [Abstract][Full Text] [Related]
14. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery.
Frässdorf J; Borowski A; Ebel D; Feindt P; Hermes M; Meemann T; Weber R; Müllenheim J; Weber NC; Preckel B; Schlack W
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1436-42, 1442.e1-2. PubMed ID: 19464461
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of Isoflurane Preconditioning-Induced Acute Cardioprotection in Hypertensive Hypertrophied Hearts.
Chen CH; Wu CW; Shih CD; Lien WH; Huang SL; Huang CC
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1317-23. PubMed ID: 27474329
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty?
Pagel PS
J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):589-93. PubMed ID: 19789055
[No Abstract] [Full Text] [Related]
17. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.
De Hert S; Vlasselaers D; Barbé R; Ory JP; Dekegel D; Donnadonni R; Demeere JL; Mulier J; Wouters P
Anaesthesia; 2009 Sep; 64(9):953-60. PubMed ID: 19686479
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane and cardioprotection.
Siracusano L; Girasole V
Br J Anaesth; 2008 Feb; 100(2):278; author reply 278-9. PubMed ID: 18212000
[No Abstract] [Full Text] [Related]
19. Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications.
Zaugg M; Lucchinetti E; Behmanesh S; Clanachan AS
Curr Pharm Des; 2014; 20(36):5706-26. PubMed ID: 24502570
[TBL] [Abstract][Full Text] [Related]
20. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.
Guarracino F; Landoni G; Tritapepe L; Pompei F; Leoni A; Aletti G; Scandroglio AM; Maselli D; De Luca M; Marchetti C; Crescenzi G; Zangrillo A
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):477-83. PubMed ID: 16884976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
